Demonstrates enhanced tumor detection using Gd-based MRI agents in tumor-bearing mice, suggesting improved early diagnosis of cancer.
-weighted signal enhancement and high tumor-to-liver contrast in Hepa1-6 tumor-bearing mice. In vivo membrane engineering strategy establishes a generalizable platform for receptor-guided molecular imaging and early cancer detection.
No takes yet. Share an insight, caveat, or question.
Mao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: